Amherst, MA, United States of America

Gregory N Tew

USPTO Granted Patents = 19 


 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 103(Granted Patents)


Location History:

  • Boston, MA (US) (2016)
  • Amherst, MA (US) (2007 - 2019)
  • South Deerfield, MA (US) (2012 - 2024)

Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: **Innovator Gregory N. Tew: Pioneering Advances in Biopharmaceuticals**

Introduction

Gregory N. Tew is a prominent inventor based in Amherst, MA, whose groundbreaking work has led to the granting of 19 patents to date. His contributions to the scientific community focus on innovative methods for delivering peptides and generating specialized T cells, providing significant potential for advancements in the treatment of autoimmune diseases.

Latest Patents

Among his latest patents is a remarkable invention titled "Cytosolic delivery of peptides using protein transduction domain mimics." This invention provides novel compositions and methods for the effective cytosolic delivery of peptides and antigens, alongside the concurrent delivery of antigens and agonists facilitated by poly-norbornene-based protein transduction domain mimics.

Another notable patent from Tew is titled "Ex vivo method of generating super regulatory T cells for the prevention of autoimmune disease." This patent discloses an ex vivo method that prepares regulatory T cells with enhanced properties. It outlines methods for utilizing this population of super regulatory T cells in the prevention, inhibition, or treatment of autoimmune disorders, promising advances in therapeutic approaches to such diseases.

Career Highlights

Gregory N. Tew has made significant strides in his career, working at esteemed institutions including the University of Massachusetts and the University of Pennsylvania. His academic and research affiliations have positioned him at the forefront of biopharmaceutical research, creating a strong impact in the field of immunology and therapeutic innovation.

Collaborations

Throughout his career, Tew has collaborated with notable peers, including William F. DeGrado and Michael L. Klein. These collaborations have enhanced his research efforts and have contributed to the development of pivotal innovations in immunotherapeutic strategies.

Conclusion

Gregory N. Tew's innovative mind and dedicated research have made substantial impacts in the fields of peptide delivery and autoimmune disease treatment. With a robust portfolio of patents and ongoing collaborations, Tew continues to shape the future of biopharmaceutical advancements, bringing forth transformative solutions that may redefine therapeutic methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…